Allison Inserro


PCOS Estimated to Cost $8 Billion in Immediate, Long-term Health Issues

September 21, 2021

An updated report shows that the long-term cost of treating the health effects of polycystic ovary syndrome (PCOS)—$4.3 billion—is even higher than $3.7 billion it takes to diagnose and treat immediate issues that present for women who are of reproductive age.

FDA Committee Votes Against COVID-19 Vaccine Booster for General Population

September 17, 2021

The advisory committee voted against COVID-19 vaccine booster shots for individuals 16 years and older, but unanimously voted for booster shots for people 65 years and older or who are at high risk of severe COVID-19.

Improving Outcomes-Based Managed Entry Agreements for SMA Therapy

September 12, 2021

Innovative therapies for rare diseases such as spinal muscular atrophy (SMA), when paid for by public budgets in the European Union and elsewhere, are often managed by agreements between payers and drug companies, but details can be hard to discern.

For Movement Disorders, Palliative Care Remains Challenging

September 10, 2021

Neuropalliative care is an emerging field for those with conditions such as Parkinson disease, multiple system atrophy, progressive supranuclear palsy, corticobasal syndrome, and other diseases, but access to care remains limited, according to a recent survey.